New non-invasive device for measuring the biomechanics of the optic nerve head

用于测量视神经乳头生物力学的新型非侵入性设备

• 批准号: 350692-2007
• 负责人: Ozaki, Tsuneyuki
• 金额: $ 9.08万
• 依托单位: Institut national de la recherche scientifique
• 依托单位国家: 加拿大
• 项目类别: Strategic Projects - Group
• 财政年份: 2008
• 资助国家: 加拿大
• 起止时间: 2008-01-01 至 2009-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=402156
• 关键词: New; non; invasive; device; measuring

Glaucoma is a group of eye diseases that share a distinct type of optic nerve damage that can lead to blindness. The prevalence of glaucoma increases markedly with age. A major difficulty of this disease is that most people who have glaucoma do not notice any symptoms until they begin to lose substantial segments of their visual field. This visual loss is permanent. The World Health Organization estimates that there are 13.5 million people with glaucoma worldwide. Currently, about 300,000 Canadians are diagnosed with glaucoma. It is estimated that another 150,000 Canadians have glaucoma but remain undiagnosed.

青光眼是一组眼部疾病，共有一种独特的视神经损伤，可导致失明。青光眼的发病率随着年龄的增长而显著增加。这种疾病的一个主要困难是，大多数青光眼患者直到开始失去视野的实质部分才注意到任何症状。这种视力丧失是永久性的。世界卫生组织估计，全世界有1350万青光眼患者。目前，约有30万加拿大人被诊断患有青光眼。据估计，另有15万加拿大人患有青光眼，但仍未确诊。